Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesAinos Inc

Ainos Inc

Technology Scientific & Technical Instruments
PortfolioPortfolio WatchlistWatchlist
Company price
0.4848 USD 0.02 ( 3.30%)
Last update at 2026-11-11T21:00:00Z
VOLUME
69439
Market Cap
10.12M

Momentum Score

…

Ainos, Inc., a dual-platform company, focusing artificial intelligence"based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.43
Low
0.49
High
52 Week Price Range
1.26
Low
4.44
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Ainos Inc (AIMD) is a NASDAQ-listed company for which publicly available disclosures provide limited detail on its core operations. Long-term growth drivers are not clearly documented; investors may find the stock's appeal contingent on future corporate disclosures, strategic milestones or clarified market exposure.
Key risks are limited transparency and disclosure, potential low liquidity and analyst coverage, and execution and financing uncertainty until the company clearly defines its business and strategy.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.47
Dividend Yield
-
Revenue TTM
0.01M
Revenue Per Share
0.00
Gross Profit TTM
0.01M
Debt / Equity
1.45
ROE
-196.30%
Net Debt
10.58M
ROCE
-71.03%
Diluted EPS TTM
-2.49

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -14.77M -14.86M -13.77M -14.01M -3.89M
Net income -14.77M -14.86M -13.77M -14.04M -3.90M
Selling general administrative 6.34M 5.40M 5.58M 8.54M 2.36M
Selling and marketing expenses - - 0.06M - -
Gross profit 0.10M -0.03M -0.25M 1.41M 0.41M
Reconciled depreciation 4.78M 4.80M 4.88M 4.83M 2.04M
Ebit -14.06M -14.25M -13.64M -13.98M -3.87M
Ebitda -9.28M -9.44M -8.77M -9.12M -1.83M
Depreciation and amortization 4.78M 4.80M 4.87M 4.86M 2.04M
Operating income -13.99M -13.84M -13.21M -13.98M -3.87M
Other operating expenses 14.11M 13.86M 13.33M 17.50M 4.46M
Interest expense 0.71M 0.62M 0.14M 0.05M 0.02M
Tax provision 0.00M 0.00M 0.00M - -
Net interest income -0.71M -0.62M -0.10M -0.05M -0.02M
Income tax expense 0.00M 0.00M 0.00M 0.03M 0.02M
Total revenue 0.12M 0.02M 0.12M 3.52M 0.59M
Total operating expenses 14.09M 13.81M 12.95M 15.38M 4.28M
Cost of revenue 0.02M 0.05M 0.38M 2.11M 0.18M
Total other income expense net -0.78M -1.02M -0.56M -0.03M -0.02M
Net income from continuing ops -14.77M -14.86M -9.98M -14.01M -3.89M
Net income applicable to common shares - - - - -3.89M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 20.87M 28.82M 31.84M 37.11M 40.82M
Intangible assets 19.23M 23.75M 28.28M 32.81M 37.33M
Other current assets 0.43M 0.30M 0.42M 0.20M 0.47M
Total liab 13.31M 13.30M 7.39M 2.48M 30.63M
Total stockholder equity 7.56M 15.52M 24.45M 34.63M 10.20M
Other current liab 0.73M 0.85M 1.18M 1.21M 27.00M
Common stock 0.07M 0.15M 0.05M 0.20M 1.44M
Capital stock 0.07M 0.15M 0.05M 0.20M 1.44M
Retained earnings -67.52M -52.75M -37.89M -24.12M -10.11M
Other assets - - - - 0.09M
Cash 0.42M 3.89M 1.89M 1.85M 1.75M
Total current liabilities 1.08M 3.95M 1.34M 2.47M 30.59M
Current deferred revenue 0.35M 0.11M 0.11M - -
Net debt 10.58M 8.11M 4.08M -0.58M 1.87M
Short term debt - 3.00M 0.04M 1.26M 3.59M
Short long term debt - 3.00M 0.04M 1.26M 29.59M
Short long term debt total 11.00M 12.00M 5.96M 1.27M 3.62M
Other stockholder equity 75.26M 68.52M 62.56M 58.75M 18.86M
Property plant equipment - - - - 1.19M
Total current assets 1.14M 4.34M 2.47M 2.85M 2.22M
Net tangible assets - - - - -27.13M
Net receivables 0.00M 0.00M 0.00M 0.20M -
Long term debt 11.00M 9.00M 5.92M - -
Inventory 0.30M 0.14M 0.17M 0.60M -
Accounts payable - - - - 1.00M
Accumulated other comprehensive income -0.25M -0.41M -0.27M -0.20M 0.01M
Non currrent assets other 0.16M 0.17M 0.21M 0.08M 0.09M
Non current assets total 19.73M 24.48M 29.37M 34.26M 38.60M
Capital lease obligations - - - 0.01M 0.03M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.13M -0.08M -0.63M -0.18M
Change to liabilities - - - - 0.85M
Total cashflows from investing activities -0.00M -0.13M -0.10M - -0.18M
Net borrowings -1.00M 8.12M 5.31M - 3.09M
Total cash from financing activities 1.01M 8.03M 4.92M 3.83M 3.15M
Change to operating activities - - - - -0.42M
Net income -14.77M -14.86M -13.77M -14.01M -3.89M
Change in cash -3.48M 2.01M 0.03M 0.10M 1.73M
Begin period cash flow 3.89M 1.89M 1.85M 1.75M 0.02M
End period cash flow 0.42M 3.89M 1.89M 1.85M 1.75M
Total cash from operating activities -4.61M -5.81M -4.69M -3.02M -1.25M
Issuance of capital stock 2.01M 0.00M 0.00M - -
Depreciation 4.78M 4.80M 4.85M 4.83M 2.04M
Other cashflows from investing activities 0.03M -0.10M -0.01M - -0.04M
Dividends paid - - 0.05M - -
Change to inventory -0.15M 0.02M 0.22M -0.60M 0.00M
Change to account receivables 0.00M 0.00M 0.20M -0.20M -0.42M
Sale purchase of stock -0.00M 0.00M -0.00M - -
Other cashflows from financing activities 1.01M -0.10M -0.39M -42.02M -42.83M
Change to netincome - - - - 0.15M
Capital expenditures 0.03M 0.02M 0.09M 0.63M 0.14M
Change in working capital 0.73M 0.04M 0.19M -0.27M 0.44M
Stock based compensation 1.73M 3.54M 1.11M 6.42M 0.15M
Other non cash items 2.92M 0.67M 2.90M - 0.00M
Free cash flow -4.65M -5.83M -4.79M -3.66M -1.39M

Peer Comparison*

Sector: Technology Industry: Scientific & Technical Instruments

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AIMD
Ainos Inc		 0.02
3.30%		 0.48 - 13.91 743.84 3.08 1654.87 -1.60
KYCCF
Keyence		 -1.77
0.38%		 470.00 41.66 38.76 0.11 5.69 0.10 0.19
COHR
Coherent Corp		 19.90
9.27%		 234.56 333.78 46.73 10.24 7.63 10.78 62.92
GRMN
Garmin Ltd		 -
-%		 293.93 28.91 24.45 7.01 5.99 6.72 22.32
KEYS
Keysight Technologies Inc		 14.18
4.87%		 305.64 42.58 20.00 8.11 8.16 8.17 28.06

Profile*

Ainos Inc

Ainos, Inc., a dual-platform company, focusing artificial intelligence"based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

3050 Post Oak Boulevard, Houston, TX, United States, 77056

281 898 6586

https://www.ainos.com

41

Name Title Year Born
Mr. Chun-Hsien Tsai Chairman of Board, Pres & CEO 1970
Ms. Hui-Lan Wu Chief Financial Officer 1961
Mr. Lawrence Kennedy Lin Exec. VP of Operations 1969
Mr. John Junyong Lee Esq. Chief Legal Counsel, Corp. Counsel & Sec. 1967
Mr. Chih-Heng Lu Corp. Sec. of Board & Director of Corp. Devel. 1980
Mr. Chun-Hsien Tsai Chairman of Board, President & CEO 1970
Mr. Lawrence Kennedy Lin Executive Vice President of Operations 1969
Mr. Hsin-Liang Lee Chief Financial Officer 1971
Mr. Chih-Heng Lu Director of Corporate Developoment 1980
Mr. Chun-Hsien Tsai CEO, President & Chairman of the Board 1970

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…